Research ArticleOriginal Article
Open Access

Phenotypic and molecular study of pneumococci causing respiratory tract infections

A 3-year prospective cohort

Amani M. Alnimr and Maha Farhat
Saudi Medical Journal April 2017, 38 (4) 350-358; DOI: https://doi.org/10.15537/smj.2017.4.17976

References

  1. ↵
    1. Tanmoy AM,
    2. Saha S,
    3. Darmstadt GL,
    4. Whitney CG,
    5. Saha SK
    (2016) PCR-based serotyping of Streptococcus pneumonia from culture-negative specimens: novel primers for detection of serotypes within serogroup 18. J Clin Microbiol 54:2178–2181.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Pimenta FC,
    2. Roundtree A,
    3. Soysal A,
    4. Bakir M,
    5. du Plessis M,
    6. Wolter N,
    7. et al.
    (2013) Sequential triplex real-time PCR assay for detecting 21 pneumococcal capsular serotypes that account for a high global disease burden. J Clin Microbiol 51:647–652.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Dransfield MT,
    2. Nahm MH,
    3. Han MK,
    4. Harnden S,
    5. Criner GJ,
    6. Martinez FJ,
    7. et al.
    (2009) Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease. Am J Resp Crit Care Med 180:499–505.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. McFetridge R,
    2. Meulen AS,
    3. Folkerth SD,
    4. Hoekstra JA,
    5. Dallas M,
    6. Hoover PA,
    7. et al.
    (2015) Safety, tolerability, and immunogenicity of 15-valent pneumococcal conjugate vaccine in healthy adults. Vaccine 33:2793–2799.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Ministry Of Health
    (2015) Pneumococcal Vaccination PCV13, Avaliable from: http://www.moh.gov.sa/en/PCV/Pages/Vaccination.aspx. [Accessed February 2017].
  6. ↵
    1. Almazrou Y,
    2. Shibl AM,
    3. Alkhlaif R,
    4. Pirçon JY,
    5. Anis S,
    6. Kandeil W,
    7. et al.
    (2016) Epidemiology of invasive pneumococcal disease in Saudi Arabian children younger than 5 years of age. J Epidemiol Glob Health 6:95–104.
    OpenUrl
  7. ↵
    1. Alharbi NS,
    2. Al-Barrak AM,
    3. Al-Moamary MS,
    4. Zeitouni MO,
    5. Idrees MM,
    6. Al-Ghobain MO,
    7. Al-Shimemeri AA,
    8. Al-Hajjaj MS
    (2016) The Saudi thoracic society pneumococcal vaccination guidelines-2016. Annals of Thoracic Medicine 11:93–102.
    OpenUrl
  8. ↵
    1. Hifumi T,
    2. Fujishima S,
    3. Abe T,
    4. Kiriu N,
    5. Inoue J,
    6. Kato H,
    7. et al.
    (2016) Prognostic factors of Streptococcus pneumonia infection in adults. Clin Am J Emerg Med 34:202–206.
    OpenUrl
  9. ↵
    1. Zowawi HM
    (2016) Antimicrobial resistance in Saudi Arabia. Saudi Med J 37:935–940.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Shibl AM,
    2. Memish ZA,
    3. Al-Kattan KM
    (2012) Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA). Vaccine 30S:G32–G36.
    OpenUrl
    1. Blair JMA,
    2. Webber MA,
    3. Baylay AJ,
    4. Ogbolu DO,
    5. Piddock LJV
    (2016) Molecular mechanisms of antibiotic resistance. Nature Rev Microbiol 13:42–51.
    OpenUrl
    1. Culbya MJ,
    2. Mo CY,
    3. Kohli RM
    (2015) Targets for combating the evolution of acquired antibiotic resistance. Biochem 54:3573–3582.
    OpenUrlCrossRef
  13. ↵
    1. Kim L,
    2. McGee L,
    3. Tomczyk S,
    4. Beall B
    (2016) Biological and epidemiological features of antibiotic-resistant Streptococcus pneumonia in pre- and post-conjugate vaccine eras: a United States perspective. Clin Microbiol Rev 29:525–552.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Chow AW,
    2. Benninger MS,
    3. Brook I,
    4. Brozek JL,
    5. Goldstein EJC,
    6. Hicks LA,
    7. et al.
    (2012) IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis 54:1041–1045.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Fukushima KY,
    2. Yanagihara K,
    3. Hirakata Y,
    4. Sugahara K,
    5. Morinaga Y,
    6. Kohno S,
    7. et al.
    (2008) Rapid identification of penicillin and macrolide resistance genes and simultaneous quantification of Streptococcus pneumoniae in purulent sputum samples by use of a novel real-time multiplex PCR assay. J Clin Microbiol 46:2384–2388.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. Wierzbowski AK,
    2. Karlowsky JA,
    3. Ada HJ,
    4. Nichol KA,
    5. Hoban DJ,
    6. Zhanel GG
    (2014) Evolution and molecular characterization of macrolide-resistant Streptococcus pneumoniae in Canada between 1998 and 2008. J Antimicrob Chemother 69:59–66.
    OpenUrlCrossRefPubMedWeb of Science
  17. ↵
    1. Shariff A,
    2. Al Dhubiab B,
    3. Al Nowis M,
    4. Al Haddad F,
    5. Al Omran N,
    6. Al Khuliteet H
    (2013) Statistical investigation of patient factor in development of antibiotic resistance –a study in eastern province of Saudi Arabia. Int J Phatm Pharm Sci 5:151–156.
    OpenUrl
  18. ↵
    1. Alsherikh YA,
    2. Gowda LK,
    3. Mohammed Ali MM,
    4. John J,
    5. Mohammed KH,
    6. et al.
    (2014) Distribution of serotypes and antibiotic susceptibility patterns among invasive pneumococcal diseases in Saudi Arabia. Ann Lab Med, 201–216.
  19. ↵
    1. Slotved HC,
    2. Kaltoft M,
    3. Skovsted IC,
    4. Kerrn MB,
    5. Espersen F
    (2004) Simple, rapid latex agglutination test for serotyping of pneumococci (Pneumotest-latex). J Clin Microbiol 42:2518–2522.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    1. Pai RP,
    2. Gertz RE,
    3. Beall B
    (2006) Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumonie isolates. J Clin Microbiol 44:124–131.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Nagai K,
    2. Shibasaki Y,
    3. Hasegawa K,
    4. Davies TA,
    5. Jacobs MR,
    6. Ubukata K,
    7. et al.
    (2001) Evaluation of PCR primers to screen for Streptococcus pneumoniae isolates and beta-lactam resistance, and to detect common macrolide resistance determinants. J Antimicrob Chemother 48:915–918.
    OpenUrlCrossRefPubMedWeb of Science
  22. ↵
    1. Grabenstein JD,
    2. Musey LK
    (2014) Differences in serious clinical outcomes of infection caused by specific pneumococcal serotypes among adults. Vaccine 32:2399–2405.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Brady AM,
    2. Calix JJ,
    3. Yu J,
    4. Geno KA,
    5. Cutter GR,
    6. Nahm MH
    (2014) Low invasiveness of pneumococcal serotype 11A is linked to ficolin-2 recognition of O-acetylated capsule epitopes and lectin complement pathway activation. J Infect Dis 210:1155–1165.
    OpenUrlCrossRefPubMed
  24. ↵
    1. Lee N,
    2. Lui GCY,
    3. Wong KT,
    4. Li TCM,
    5. Tse ECM,
    6. Chan JYC,
    7. et al.
    (2013) High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections. Clin Infect Dis 57:1069–1077.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Geno KA,
    2. Gilbert GL,
    3. Song JY,
    4. Skovsted IC,
    5. Klugman KP,
    6. Jones C,
    7. et al.
    (2015) Pneumococcal capsules and their types: Past, present and future. Clin Microbiol Rev 28:871–899.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Mousavi SF,
    2. Nobari N,
    3. Ghezelgeh FR,
    4. Lyriai H,
    5. Jalali P,
    6. Shahecheraghi F,
    7. et al.
    (2013) Serotyping of Streptococcus pneumoniae isolated from Tehran by multiplex PCR: Are serotypes of clinical and carrier isolates identical? Iran J Microbiol 5:220–226.
    OpenUrl
  27. ↵
    1. Hanna-Wakim R,
    2. Chehab H,
    3. Mahfouz I,
    4. Nassar F,
    5. Baroud M,
    6. Shehab M,
    7. et al.
    (2012) Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon. Vaccine 30S:G11–G17.
    OpenUrl
  28. ↵
    1. Soto-Noguerón A,
    2. Carnalla-Barajas MN,
    3. Solórzano-Santos F,
    4. Arrendondo-Garcia JL,
    5. Arzate-Barbosa PP,
    6. Tinoco-Favila JC,
    7. et al.
    (2016) Streptococcus pneumonia as cause of infection in infants less than 60 days of age: Serotypes and antimicrobial susceptibility. Int J Infect Dis 42:69–73.
    OpenUrl
  29. ↵
    1. Pilishvili T,
    2. Bennett NM
    (2015) Pneumococcal disease prevention among adults: Strategies for the use of pneumococcal vaccines. Vaccine 33:D60–D65.
    OpenUrlCrossRefPubMed
  30. ↵
    1. Kietzman CC,
    2. Gao G,
    3. Mann B,
    4. Myers L,
    5. Tuomanen EI
    (2016) Dynamic capsule restructuring by the main pneumococcal autolysin LytA in response to the epithelium. Nat Commun, DOI:10.1038/ncomms10859.
  31. ↵
    1. Kurola P,
    2. Erkkila L,
    3. Kaijalainen T,
    4. Palmu AA,
    5. Hausdorff WP,
    6. Poolman J,
    7. et al.
    (2010) Presence of capsular locus genes in immunochemically identified encapsulated and unencapsulated Streptococcus pneumonia sputum isolates obtained from elderly patients with acute lower respiratory tract infection. J Med Microbiol 59:1140–1145.
    OpenUrlCrossRefPubMed
  32. ↵
    1. Selva L,
    2. Berger C,
    3. Garcia-Garcia JJ,
    4. de Paz H,
    5. Nadal D,
    6. Muñoz-Almagro C
    (2014) Direct identification of Streptococcus pneumoniae capsular types in pleural fluids by using multiplex PCR combined with automated fluorescence-based capillary electrophoresis. J Clin Microbiol 52:2736–2737.
    OpenUrlFREE Full Text
  33. ↵
    1. Shibl AM
    (2008) Distribution of serotypes and antibiotic resistance of invasive pneumococcal disease isolates among children aged 5 years and under in Saudi Arabia (2000–2004). Clin Microbiol Infect 14:876–879.
    OpenUrlPubMed
  34. ↵
    1. Dixit C,
    2. Keller LE,
    3. Bradshaw JL,
    4. Robinson DA,
    5. Swiatlo E,
    6. McDaniel LS
    (2016) Nonencapsulated Streptococcus pneumonia as a cause of chronic adenoiditis. IDCases 4:56–58.
    OpenUrl
    1. World Health Organization
    (2012) Pneumococcal vaccines WHO position paper-2010-Recommendations. Vaccine 30:4717–4718.
    OpenUrlCrossRefPubMedWeb of Science
  36. ↵
    1. Taha N,
    2. Araj RH,
    3. Wakim RH,
    4. Kanj SS,
    5. Kanafani ZA,
    6. Sabra A,
    7. et al.
    (2012) Genotypes and serotype distribution of macrolide resistant invasive and non-invasive Streptococcus pneumoniae isolates from Lebanon. Ann Clin Microbiol Antimicro 11:2.
    OpenUrl
  37. ↵
    1. Motaweq ZY,
    2. Al-Dahhan HAA,
    3. Naher HS
    (2015) Detection of macrolide resistance genes ermB and mefA/E in Iraq. World J Pharma Res 4:252–265.
    OpenUrl
  38. ↵
    1. Mandell LA,
    2. Wunderink RG,
    3. Anzueto AA,
    4. Bartlett JG,
    5. Campbell JD,
    6. Dean NC,
    7. Dowell SF,
    8. File TM,
    9. Musher DM,
    10. Niederman SM,
    11. Torres A,
    12. Whitney CG
    (2007) Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44:S27–S72.
    OpenUrlCrossRefPubMedWeb of Science
  39. ↵
    1. Setchanova LP,
    2. Ouzounova-Raykova V,
    3. Zhelezova GZ,
    4. Mitov IG
    (2007) Prevalence and macrolide resistance phenotypes and genotypes among clinical isolates of Streptococcus pneumoniae collected in Sofia, Bulgaria from 2001 to 2005. J Chemother 19:327–333.
    OpenUrl
  40. ↵
    1. Pai R,
    2. Gertz RE,
    3. Whitney CG,
    4. Beall B
    (2005) Clonal association between Streptococcus pneumoniae serotype 23A, circulating within the United States, and an internationally dispersed clone of serotype 23F. J Clin Microbiol 43:5440–5444.
    OpenUrlAbstract/FREE Full Text
  41. ↵
    1. Engelhard D,
    2. Pomeranz S,
    3. Gallily R,
    4. Strauss N,
    5. Tuomanen E
    (1997) Serotype-related differences in inflammatory response to Streptococcus pneumoniae in experimental meningitis. J Infect Dis 175:979–982.
    OpenUrlCrossRefPubMedWeb of Science
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section